Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Methylaspartate ammonia-lyase is an enzyme (EC 4.3.1.2) predominantly found in certain bacteria (e.g., Citrobacter, Clostridium), where it plays a key role in the catabolism of glutamate via the methylaspartate pathway and in nitrogen metabolism. The enzyme catalyzes the reversible deamination of L-threo-3-methylaspartate to produce mesaconate and ammonia, employing magnesium or cobamide as cofactors. Structurally, it is a homodimer with a TIM barrel domain and belongs to the enolase superfamily. MAL’s catalytic mechanism involves abstraction of a proton alpha to the carboxyl group of methylaspartate, followed by elimination of ammonia, a process important for bacterial fermentation in anaerobic conditions. There are no clinically relevant drugs, safety concerns, or disease roles associated with this enzyme in humans, but it is a well-characterized tool in microbial biochemistry and metabolic engineering[1][2][3][4][5][7][10].
Catalyzes the reversible alpha,beta-elimination of ammonia from L-threo-3-methylaspartic acid to form mesaconate Requires magnesium (Mg2+) or, in some forms, cobamide as cofactors[1][2][3] Utilizes a base-catalyzed abstraction of a proton followed by elimination of ammonia, forming an enolate intermediate[5][7]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Methylaspartate ammonia-lyase (MAL).